Thursday, August 15, 2019 6:34:11 AM
Excellent profit margins, balamidas
66% is really fantastic at this stage in the game
With larger production runs of CBD Beverages over time, production prices will fall and profit margins should rise even further
It also looks like VATE will be cash flow positive in Q3, which should decrease any dilution necessary to find operations moving forward
I’ve seen some remark that they expected the revenues to be higher due to Q2 being the first quarter where CBD Beverage revenue hit the books
But the CBD Coffee didn’t launch until May and the CBD Iced Tea launched in June, so most of the revenues from the first production run of 60,000 units got pushed into Q3
VATE now has over 20 distributors, but only 4 distributors received product during Q2
So 80% of the CBD Beverage revenue to date will fall in Q3
Subtract out the O2 Breathe revenue because they went their separate ways at the end of Q1 and the Q2 revenues are in line with what I expected
I’m expecting a huge jump in Q3 revenues due to the fact that this will be the first full quarter of CBD Beverage revenue and VATE’s distribution network is now 5X larger than it was in Q2 and we still have 45 days remaining in this quarter
So Q3 is when we will get a much better sense of VATE’s revenue stemming from their new CBD Beverages, as they are on track for 25-30 distributors by the end of Q3 — VATE only signed 4 distributors in Q2— so you can multiply their Q2 CBD Beverage revenue by 6X-7X to calculate the expected CBD Beverage revenue in Q3
Sleek
66% is really fantastic at this stage in the game
With larger production runs of CBD Beverages over time, production prices will fall and profit margins should rise even further
It also looks like VATE will be cash flow positive in Q3, which should decrease any dilution necessary to find operations moving forward
I’ve seen some remark that they expected the revenues to be higher due to Q2 being the first quarter where CBD Beverage revenue hit the books
But the CBD Coffee didn’t launch until May and the CBD Iced Tea launched in June, so most of the revenues from the first production run of 60,000 units got pushed into Q3
VATE now has over 20 distributors, but only 4 distributors received product during Q2
So 80% of the CBD Beverage revenue to date will fall in Q3
Subtract out the O2 Breathe revenue because they went their separate ways at the end of Q1 and the Q2 revenues are in line with what I expected
I’m expecting a huge jump in Q3 revenues due to the fact that this will be the first full quarter of CBD Beverage revenue and VATE’s distribution network is now 5X larger than it was in Q2 and we still have 45 days remaining in this quarter
So Q3 is when we will get a much better sense of VATE’s revenue stemming from their new CBD Beverages, as they are on track for 25-30 distributors by the end of Q3 — VATE only signed 4 distributors in Q2— so you can multiply their Q2 CBD Beverage revenue by 6X-7X to calculate the expected CBD Beverage revenue in Q3
Sleek
SLEEKSCAPE’S GRAND SALAMI FOR 2019 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE’S-2019-HEMP-CBD-&-MARIJUANA-MANIA-GRAND-SALAMI-PART-II-31243/
Recent BLEG News
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • InvestorsHub NewsWire • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • GlobeNewswire Inc. • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • InvestorsHub NewsWire • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • GlobeNewswire Inc. • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • GlobeNewswire Inc. • 12/10/2025 02:17:29 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • InvestorsHub NewsWire • 12/10/2025 02:00:00 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • GlobeNewswire Inc. • 11/25/2025 03:38:40 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • InvestorsHub NewsWire • 11/25/2025 03:11:49 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • InvestorsHub NewsWire • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • GlobeNewswire Inc. • 10/22/2025 03:17:40 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • InvestorsHub NewsWire • 10/22/2025 02:56:16 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • InvestorsHub NewsWire • 09/30/2025 12:30:00 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • GlobeNewswire Inc. • 09/23/2025 02:44:55 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • InvestorsHub NewsWire • 09/23/2025 01:40:59 PM
- Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions • InvestorsHub NewsWire • 08/22/2025 05:39:40 PM
- Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways • InvestorsHub NewsWire • 08/19/2025 12:39:04 PM
- Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery • InvestorsHub NewsWire • 07/29/2025 12:30:00 PM
- Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • InvestorsHub NewsWire • 07/14/2025 05:23:12 PM
